Navigation Links
Indiana U. professor to examine how women respond to information about the HPV vaccine
Date:9/22/2011

FOR IMMEDIATE RELEASE Sept. 21, 2011

INDIANAPOLIS, Ind. -- Dena S. Cox, a professor of marketing and faculty fellow at the Kelley School of Business Indianapolis, has received a $99,600, two-year research grant from Merck to study factors influencing young women's adoption of the human papillomavirus (HPV) vaccine.

Cox's research investigates how people make medical-treatment decisions, examining the effects of health communication on consumers' adoption of preventive behaviors. In the study, she is exploring the most effective ways to present information to women ages 18 to 26 about the benefits and risks of the HPV vaccine.

HPV is the most common sexually transmitted infection, according to the Centers for Disease Control and Prevention. Most people with the virus do not develop symptoms or health problems. However, some HPV types can cause genital warts and cervical cancer.

In the study, Cox will employ a nationwide, Internet survey panel to recruit young women who have not received the HPV vaccine. She will present them with information on vaccination benefits and risks, in a variety of presentation formats.

The study will then assess the women's understanding of this information, their attitudes and intentions toward vaccination, and, six months later, their vaccination behavior. The study seeks to determine which presentation formats are most helpful to young women in making informed decisions about HPV vaccination.

"Medical information often is complex," said Cox. "How you frame the information and its personal impact will influence the way people think and behave. We believe that the more an individual processes and understands the information, the more likely she is to participate in a healthy action, like HPV vaccination."

Each year, about 12,000 women in the U.S. get cervical cancer, and about 4,000 die from the disease. Cervical cancer largely is preventable through Pap screening tests and the HPV vaccination. However, healthy women in their late teens and early 20s may not consider themselves at risk. Cox's study will help health care professionals better communicate with young women about the risks of cervical cancer and the importance of preventive measures, including HPV vaccination.

This is Cox's second research grant from Merck. Her co-investigators on this study include Anthony Cox, Chancellor's Faculty Fellow and professor of marketing at Kelley, and Gregory Zimet, professor of pediatrics and co-leader of the Cancer Control program in the IU School of Medicine. The Kelley School Indianapolis is based at the Indiana University-Purdue University Indianapolis campus.


'/>"/>

Contact: Brenda Bishop
bbishop@iupui.edu
317-274-5483
Indiana University
Source:Eurekalert  

Related medicine news :

1. New book by Indiana University physicians slays health myths we all thought were true
2. Indiana University neuroscientists map a new target to wipe pain away
3. Indiana U. study points to health disparities in physical fitness
4. A safer, more effective morphine may be possible with Indiana University discovery
5. Grant launches cervical cancer-free Indiana initiative
6. APHA 2010: Study finds funding for substance abuse in Indiana lacking
7. Indianapolis to host international conference on frontotemporal dementias
8. NRPA Launches National Hunger Relief Initiative at Indianapolis' Douglass Park
9. Indiana Home and Hospice Care Foundation Selects Pearson to Bolster Workforce Training Initiatives
10. National Insurance Company Looks to Indianapolis-based TriDigital Solutions for Affordable CD Replication and Mailing Project
11. Indiana Boudoir Photographer Begins Shooting Breast Cancer Charity Calendar
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Indiana U. professor to examine how women respond to information about the HPV vaccine
(Date:2/23/2017)... ... February 23, 2017 , ... Top cosmetic and periodontal ... program today with a new Indiegogo campaign . Individuals are now able ... in the Los Angeles area, either as a participating patient or through an Indiegogo ...
(Date:2/23/2017)... ... February 23, 2017 , ... HealthPostures, the desk for ... expert sit stand solutions representative to the Minneapolis Home and Garden Show which is ... event that is garnering national attention is the Minneapolis Convention Center. , From ...
(Date:2/23/2017)... ... February 23, 2017 , ... Carlos Gutierrez ... has also continued to spiritually evolve, which is the purpose of everyone in this ... Spiritual Truths ” (published by Balboa Press) attempts to guide readers to expand one’s ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... athletics. It’s enough to overwork even the sharpest brain. , Power On, a ... healthy activity without over clocking the brain. Each capsule contains Cognizin® Citicoline, a ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... medicine in recent years. The technology is so cutting edge, in fact, the ... protocol for stem cell procedures. However, successful patient outcomes in certain clinical stem ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... DUBLIN , Feb 23, 2017 Research ... Prosthetic Devices Market Analysis & Trends - Industry Forecast to 2025" ... ... to grow at a CAGR of around 9.2% over the next ... industry report analyzes the market estimates and forecasts for all the ...
(Date:2/23/2017)... 23, 2017 MabVax Therapeutics Holdings, ... development company, announces that it has received notice ... authorizing the initiation a Phase I clinical trial ... cancer. MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is the Company,s ... to initiate the phase I clinical trial in ...
(Date:2/23/2017)... , Feb. 22, 2017 Orthopedic ... implant demand, as aging demographic patterns lead to ... Implants for sports- and exercise-related injuries, chronic back ... will lead sales gains. The future of medical ... addresses the following questions and more: - ...
Breaking Medicine Technology: